FAAH
Read More about this categoryShow Less
Fatty acid amide hydrolase (FAAH), belonging to an amidase-signature (AS) protein family, is a membrane-bound protein predominantly in microsomal and mitochondrial fractions that catalyzes the hydrolysis of several bioactive lipids, including anandamide, 2-arachidonoylglycerol (2-AG) and oleamide. The mammalian FAAHs are 63 kDa (579 amino acids in length) proteins characterized by containing several domains defined by homology and function, including, a highly conserved seine-and-glycine-rich AS domain, a predicted transmembrane domain and a proline rich domain. Results of mutation studies suggest, unlike other members of AS protein family, the catalytic activity of FAAH is not associated with the Ser-His-Asp triad but possibly with Ser217 and Lys142.
Products Related to FAAH(36)
- GC12031Monoacylglycerol Lipase Inhibitor 21CAS: 1643657-35-5Purity: >98%
inhibitor of monoacylglycerol lipase (MAGL) and FAAH
- GC13063N-BenzylpalmitamideCAS: 74058-71-2Purity: >98.00%
inhibitor of fatty acid amide hydrolase (FAAH)
- GC15231Oleoyl Ethyl AmideCAS: 85075-82-7Purity: >98.00%
FAAH inhibitor with potential analgesic and anxiolytic activity
- GC171594-(n-nonyl) Benzeneboronic AcidCAS: 256383-45-6Purity: >98%
4-(n-nonyl) Benzeneboronic Acid (compound 13) is a potent FAAH and MAGL dual inhibitor with IC50 values of 9.1 nM and 7.9 μM, respectively.
- GC18174BIA 10-2474CAS: 1233855-46-3Purity: >98.00%
BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH; IC50 = 4.9 nM in HEK293T cells expressing the human recombinant enzyme).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11290 | TC-F 2 | 1304778-15-1 | >98% | |
FAAH inhibitor | ||||
| GC12693 | JZL 195 | 1210004-12-8 | >98.00% | |
JZL 195 is a highly selective and irreversible dual inhibitor of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), with IC 50 values of 2nM and 4nM, respectively. | ||||
| GC15077 | SA 47 | 792236-07-8 | >99.00% | |
FAAH inhibitor | ||||
| GC15358 | PF 750 | 959151-50-9 | >98.00% | |
FAAH inhibitor | ||||
| GC17855 | SA 57 | 1346169-63-8 | >98% | |
FAAH inhibitor | ||||
| GC10133 | JNJ-42165279 | 1346528-50-4 | >99.50% | |
FAAH inhibitor | ||||
| GC12031 | Monoacylglycerol Lipase Inhibitor 21 | 1643657-35-5 | >98% | |
inhibitor of monoacylglycerol lipase (MAGL) and FAAH | ||||
| GC12546 | JP83 | 887264-44-0 | >98% | |
irreversible fatty acyl amide hydrolase (FAAH) inhibitor | ||||
| GC13063 | N-Benzylpalmitamide | 74058-71-2 | >98.00% | |
inhibitor of fatty acid amide hydrolase (FAAH) | ||||
| GC13953 | Methyl α-Linolenyl Fluorophosphonate | - | >98% | |
inhibitor of phospholipases, FAAH | ||||
| GC13963 | Oleyl Trifluoromethyl Ketone | 177987-23-4 | >98% | |
potent inhibitor of FAAH | ||||
| GC14581 | JNJ-1661010 | 681136-29-8 | >98.50% | |
A selective FAAH inhibitor | ||||
| GC15094 | LY2183240 | 874902-19-9 | >99.00% | |
A potent, competitive inhibitor of anandamide uptake | ||||
| GC15210 | PF-622 | 898235-65-9 | >98% | |
potent, time-dependent, irreversible FAAH inhibitor | ||||
| GC15231 | Oleoyl Ethyl Amide | 85075-82-7 | >98.00% | |
FAAH inhibitor with potential analgesic and anxiolytic activity | ||||
| GC15951 | URB597 | 546141-08-6 | >98.00% | |
URB597 is an orally active fatty acid amide hydrolase (FAAH) inhibitor (IC 50 =0.5-5nM). | ||||
| GC16033 | TAK 21d | 1143578-94-2 | >98% | |
TAK 21d (compound 21d) is a potent, orally active and cross the blood-brain barrier fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 0.72, 0.28 nM for hFAAH, rFAAH, respectively. | ||||
| GC16984 | PF-3845 | 1196109-52-0 | >99.50% | |
PF-3845 is a dual inhibitor targeting fatty acid amide hydrolase (FAAH) and soluble epoxide hydrolase (sEH), with EC 50 values of 0.65nM and 12000nM, respectively. | ||||
| GC17159 | 4-(n-nonyl) Benzeneboronic Acid | 256383-45-6 | >98% | |
4-(n-nonyl) Benzeneboronic Acid (compound 13) is a potent FAAH and MAGL dual inhibitor with IC50 values of 9.1 nM and 7.9 μM, respectively. | ||||
| GC17341 | Carprofen | 53716-49-7 | >99.50% | |
COX inhibitor | ||||
| GC18174 | BIA 10-2474 | 1233855-46-3 | >98.00% | |
BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH; IC50 = 4.9 nM in HEK293T cells expressing the human recombinant enzyme). | ||||
| GC30366 | FAAH-IN-2 | 184475-71-6 | >99.40% | |
FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2. | ||||
| GC30751 | FAAH-IN-1 | 1242441-47-9 | >98% | |
FAAH-IN-1 is a fatty acid amide hydrolase (FAAH) inhibitor, with IC50s of 145 nM and 650 nM for rat and human FAAH, respectively. | ||||
| GC31239 | SA72 | 934809-60-6 | >98% | |
SA72 is a highly selective fatty acid amide hydrolase (FAAH) inhibitor. | ||||
